B
BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LTD.
BDR Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, comprising of API and formulation manufacturing, focuses on development in 4 ...
Country/Area ：India
Company Email ：enquiry@bdrpharma.com
Industry ：Sports & EntertainmentElectronicsHealthcareSchool & Office SuppliesPharmaceuticals
Company address ：6TH FLOOR, ENGINEERING CENTRE 9 MAT MUMBAI
Company website ：*****
Company phone ：+91 2240560560
Established ：2002
Company Revenue ：$21,609,000
Number of employees ：79
SIC Code ：28283
NAICS Code ：32325
Main Products ：Job OpeningsTrade ExhibitsRegulatoryContract ManufacturingResearch & DevelopmentIPRBoard Of DirectorsDisclaimerFacilitiesMilestonesGlobal PresenceInnovation & TechnologyMessage From The MDCSR SustainabilityCulture
Company News
Procaps Group Announces the Expansion of its Oncology Portfolio
Sep 7, 2023
MIAMI & BARRANQUILLA, Columbia--(BUSINESS WIRE)--Procaps Group Announces the Expansion of its Oncology Portfolio
Sep 7, 2023
CCI approves deal to acquire minority stake in BDR Pharmaceuticals | Business - DevdiscourseApr 18, 2022
Read more about CCI approves deal to acquire minority stake in BDR Pharmaceuticals on Devdiscourse
Apr 18, 2022Global private equity funds in talks to purchase minority stake in BDR PharmaceuticalsJul 23, 2021
Funds like the Carlyle Group, Warburg Pincus and TA Associates are engaged in initial discussions, the people added. Investment bank O3 Capital is advising the promoters. In 2018, Shah had tried his luck to sell minority stake and had discussions with funds like Carlyle, but it did not fructify.
Jul 23, 2021Web Summary
Q1: What is the registered office address of BDR Pharmaceuticals International Pvt. Ltd.?
A1: The registered office address of BDR Pharmaceuticals International Pvt. Ltd. is 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.
Q2: What is the contact number for BDR Pharmaceuticals International Pvt. Ltd.?
A2: The contact number for BDR Pharmaceuticals International Pvt. Ltd. is +91-22-40560560.
Q3: Who is the grievance officer at BDR Pharmaceuticals International Pvt. Ltd.?
A3: Mr. Pawan Srivastava is the grievance officer at BDR Pharmaceuticals International Pvt. Ltd.
Q4: What is the email address for grievances at BDR Pharmaceuticals International Pvt. Ltd.?
A4: The email address for grievances at BDR Pharmaceuticals International Pvt. Ltd. is Ombudsman@bdrpharma.com.
Q5: Where can one find more information about BDR's products and services?
A5: BDR Pharmaceuticals International Pvt. Ltd. has various product categories such as APIs, Finished Formulations, Oncology Oral Dosage, and more, which can be found on their website or by contacting them directly.
Q6: What is the company's approach to making high-end products available at affordable prices?
A6: The company aims to make high-end products available at affordable prices to suffering communities worldwide, driven by the necessity to provide quality medicines to patients in need.
Q7: How does BDR Pharmaceuticals International Pvt. Ltd. ensure the quality of its products and services?
A7: The company has world-class state-of-the-art facilities located within the same campus, which have accreditations from WHO GMP, EU GMP, and are poised for more audits in the near future.
Q8: What is BDR Pharmaceuticals International Pvt. Ltd.'s stance on intellectual property rights (IPR)?
A8: The company has a strong commitment to IPR, including manufacturing and exporting unique and new APIs, and is trend setter in critical and life-threatening segments.
Q9: How does BDR Pharmaceuticals International Pvt. Ltd. approach formulation development of molecules?
A9: The company is a front runner in terms of formulation development of molecules, technology, and dosage forms with competitive edge and commercial viability that are manufactured in units having Global cGMP certification.
Q10: What is the company's focus on product development, particularly in niche areas?
A10: Emphasis is laid upon new and niche product development, including sustained and modified pellets using innovative drug delivery technologies with latest manufacturing technologies.
A1: The registered office address of BDR Pharmaceuticals International Pvt. Ltd. is 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.
Q2: What is the contact number for BDR Pharmaceuticals International Pvt. Ltd.?
A2: The contact number for BDR Pharmaceuticals International Pvt. Ltd. is +91-22-40560560.
Q3: Who is the grievance officer at BDR Pharmaceuticals International Pvt. Ltd.?
A3: Mr. Pawan Srivastava is the grievance officer at BDR Pharmaceuticals International Pvt. Ltd.
Q4: What is the email address for grievances at BDR Pharmaceuticals International Pvt. Ltd.?
A4: The email address for grievances at BDR Pharmaceuticals International Pvt. Ltd. is Ombudsman@bdrpharma.com.
Q5: Where can one find more information about BDR's products and services?
A5: BDR Pharmaceuticals International Pvt. Ltd. has various product categories such as APIs, Finished Formulations, Oncology Oral Dosage, and more, which can be found on their website or by contacting them directly.
Q6: What is the company's approach to making high-end products available at affordable prices?
A6: The company aims to make high-end products available at affordable prices to suffering communities worldwide, driven by the necessity to provide quality medicines to patients in need.
Q7: How does BDR Pharmaceuticals International Pvt. Ltd. ensure the quality of its products and services?
A7: The company has world-class state-of-the-art facilities located within the same campus, which have accreditations from WHO GMP, EU GMP, and are poised for more audits in the near future.
Q8: What is BDR Pharmaceuticals International Pvt. Ltd.'s stance on intellectual property rights (IPR)?
A8: The company has a strong commitment to IPR, including manufacturing and exporting unique and new APIs, and is trend setter in critical and life-threatening segments.
Q9: How does BDR Pharmaceuticals International Pvt. Ltd. approach formulation development of molecules?
A9: The company is a front runner in terms of formulation development of molecules, technology, and dosage forms with competitive edge and commercial viability that are manufactured in units having Global cGMP certification.
Q10: What is the company's focus on product development, particularly in niche areas?
A10: Emphasis is laid upon new and niche product development, including sustained and modified pellets using innovative drug delivery technologies with latest manufacturing technologies.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
